| abstract |
The present invention relates to novel salicylicanilide compounds useful as antibiotics. More specifically, the present invention is a novel salicylic anilide compound of formula (1), which is a compound useful as an antimicrobial agent and particularly has a strong activity against strains such as methicillin resistant Staphylococcus aureus (MRSA), pharmaceutical To non-toxic salts thereof, physiologically hydrolysable esters thereof, hydrates and solvates thereof, and isomers thereof.n n n n n n n n n n Wheren n n R, X, Y, Z, A, Q 1 , G and J are each as mentioned in the specification. |